<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140417" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Incontinentia Pigmenti (Bloch-Sulzberger Syndrome)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yadlapati</surname>
            <given-names>Sujitha</given-names>
          </name>
          <aff>HCA Bay area Corpus Christi Medical Center Dermatology Residency Program</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sujitha Yadlapati declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140417.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Incontinentia pigmenti is an X-linked dominant genodermatosis. The disease is caused by a mutation of the IKBKG gene. This rare disorder presents in the first few weeks of life. Skin lesions are typical of this disease. The eye, teeth, and central nervous system are also involved. Due to multisystemic involvement, it must be promptly diagnosed and treated. Genetic counseling plays an important part in the management. This activity reviews the evaluation and diagnosis of incontinentia pigmenti and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Summarize the etiology of incontinentia pigmenti.</p></list-item><list-item><p>Outline the histopathology of skin lesions and the typical presentation of a patient with incontinentia pigmenti.</p></list-item><list-item><p>Summarize the differential diagnoses of incontinentia pigmenti.</p></list-item><list-item><p>Review the appropriate management for patients with incontinentia pigmenti.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140417&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140417">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140417.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Incontinentia pigmenti (IP) or Bloch-Sulzberger syndrome, is a rare X-linked dominant genodermatosis.&#x000a0;Other names of this disorder include Bloch&#x02013;Siemens syndrome, Bloch&#x02013;Sulzberger disease, melanoblastosis cutis, pigmented dermatosis Siemens-Bloch type, and nevus pigmentosus systematicus. IP is the consequence of a mutation in the IKBKG gene (formerly known as NEMO or nuclear factor kappa essential modulator).<xref ref-type="bibr" rid="article-140417.r1">[1]</xref>&#x000a0;</p>
        <p>Incontinentia pigmenti clinically presents with&#x000a0;skin, central nervous system, eyes, teeth, hair, and nail involvement. This rare condition usually presents within the first few weeks of life and is most commonly seen in females and rarely in males. IP is usually fatal&#x000a0;in male infants; females show variable phenotypic presentation and survive due to lyonization, as seen in many X-linked disorders.<xref ref-type="bibr" rid="article-140417.r2">[2]</xref> Skin involvement is one of the first to be noted and progresses through four stages: vesicular, verrucous, hyperpigmented, and hypopigmented/atrophic stage.<xref ref-type="bibr" rid="article-140417.r3">[3]</xref>&#x000a0;The central nervous system (CNS) manifestations and eye manifestations can cause&#x000a0;severe disability in these patients.<xref ref-type="bibr" rid="article-140417.r4">[4]</xref>&#x000a0;</p>
        <p>The diagnosis of&#x000a0;IP can be made clinically and confirmed with genetic testing. Management of IP requires a multidisciplinary approach, including referral to pediatric dermatology for management of blisters, prevention of secondary skin infections; dental care; screening by an ophthalmologist to reduce the risk of retinal detachment; referral to pediatric neurology for management of seizures and neurological deficits; care by a pediatrician and developmental specialists to address the developmental delay.<xref ref-type="bibr" rid="article-140417.r3">[3]</xref></p>
        <p>The low incidence of this condition worldwide makes diagnosis and prompt management a challenge. Surveillance and medical management protocols have been established by the Incontinentia Pigmenti International Foundation&#x000a0;and the National Foundation for Ectodermal Dysplasias.</p>
      </sec>
      <sec id="article-140417.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Incontinentia pigmenti is a disorder of X-linked inheritance.&#x000a0;Most affected individuals have a&#x000a0;<italic toggle="yes">de novo</italic> mutation of the IKBKG (inhibitor of kappaB kinase gamma) or IKK gamma or&#x000a0;NF-kappa-B essential modulator (NEMO) gene on chromosome Xq28.<xref ref-type="bibr" rid="article-140417.r1">[1]</xref> IKBKG activates NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells), which is involved in apoptosis (cell survival), cell cycle, inflammation, immunity, and other pathways.<xref ref-type="bibr" rid="article-140417.r5">[5]</xref></p>
        <p>Normally, NF-kB protects against cell death; it is maintained within cells in an inactive state and becomes activated to induce an inflammatory response secondary to bacterial, viral, or stress.&#x000a0;Derangement of IKBKG results in its inability to protect cells against apoptosis; hence more cell death occurs in response to stimuli.<xref ref-type="bibr" rid="article-140417.r6">[6]</xref>&#x000a0;</p>
        <p>Due to X-linked dominant inheritance, IP&#x000a0;is usually lethal in males during embryogenesis.<xref ref-type="bibr" rid="article-140417.r7">[7]</xref>&#x000a0;However, cases in males have been reported in the literature.&#x000a0;This can be explained by somatic mosaicism, hypomorphic mutations, or the presence of an extra X chromosome, as in&#x000a0;Klinefelter syndrome.&#x000a0;Females inherit one X chromosome from each parent, and one X chromosome becomes inactivated through lyonization. Inactivation of a single X chromosome is not seen in all cells. Therefore, females are functionally mosaic,&#x000a0;meaning they have two cell lines. Skin lesions develop along the Blaschko's lines.<xref ref-type="bibr" rid="article-140417.r8">[8]</xref> These lines reflect embryonic stem cells' migration path during development and are invisible unless a pigmentary skin disorder is present.<xref ref-type="bibr" rid="article-140417.r9">[9]</xref></p>
      </sec>
      <sec id="article-140417.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Due to the X-linked inheritance pattern, women affected by incontinentia pigmenti have a 50% chance of transmitting the pathogenic version of IKBKG to offspring; male fetuses with a defective gene are usually miscarried.<xref ref-type="bibr" rid="article-140417.r7">[7]</xref>&#x000a0;In a systematic review, 1393 cases of IP were reported from the literature analysis from 1993 to 2012.<xref ref-type="bibr" rid="article-140417.r10">[10]</xref><xref ref-type="bibr" rid="article-140417.r11">[11]</xref>&#x000a0;</p>
        <p>The number of cases both in females and males continues to grow. The prevalence of IP is estimated to be 0.7/1,000,0000 cases worldwide.<xref ref-type="bibr" rid="article-140417.r12">[12]</xref>&#x000a0;The majority of the living individuals with the disease are females (92 to 97%).<xref ref-type="bibr" rid="article-140417.r13">[13]</xref>&#x000a0;There are around 28 new cases of IP each year globally.</p>
      </sec>
      <sec id="article-140417.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Incontinentia pigmenti affects all cells of ectodermal origin, including skin, hair, nails, and teeth.<xref ref-type="bibr" rid="article-140417.r14">[14]</xref> CNS involvement is not clearly understood, but NF-kB is present in most cells, including the central nervous system, and protects the integrity of the blood-brain barrier by protecting against cell death.<xref ref-type="bibr" rid="article-140417.r15">[15]</xref>&#x000a0;As seen in X-linked disorders, lyonization in affected females results in functional mosaicism and manifests as cutaneous lesions in Blaschkoid distribution.</p>
        <p>NF-kB is a transcription factor involved in expressing multiple genes, including cytokines, chemokines, growth factors, adhesion molecules, and regulators of apoptosis.<xref ref-type="bibr" rid="article-140417.r16">[16]</xref><xref ref-type="bibr" rid="article-140417.r17">[17]</xref>&#x000a0;NF-kB activation prevents apoptosis induced by the tumor necrosis factor (TNF) family of cytokines.&#x000a0;NF-kB is mainly inactive in most cells, and various stimuli trigger activation of NF-kB.&#x000a0;These stimuli include interleukin-1 (IL-1), TNF alpha, antigen receptors (T-cell receptor and B-cell receptor), genotoxic stress (ultraviolet radiation, gamma radiation, reactive oxygen intermediates), lipopolysaccharide (bacterial endotoxin), and double-stranded RNA (viral infection).<xref ref-type="bibr" rid="article-140417.r18">[18]</xref>&#x000a0;</p>
        <p>The 'canonical'&#x000a0;NF-kB is a heterodimer consisting of&#x000a0;p50 and p65 (RelA).<xref ref-type="bibr" rid="article-140417.r19">[19]</xref> NF-kB is kept inactivated in the cytosol when it is complexed with inhibitory protein I&#x003ba;B&#x003b1; (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha).&#x000a0;Various stimuli activate the I&#x003ba;B kinase (IKK) after attaching to and activating the receptors. IKK phosphorylates IkB, which leads to the degradation of IkB and thereby activation of NF-kB. Activated NF-kB<italic toggle="yes">&#x000a0;</italic>enters the nucleus to bind with response elements (RE) of DNA (deoxyribonucleic acid) and brings out the various changes in cellular functions.<xref ref-type="bibr" rid="article-140417.r20">[20]</xref>&#x000a0;The mutation of IKK results in complete disruption of the signaling pathway and virtually no NF-kB activity after stimulation of NEMO/IKK-deficient cells.</p>
        <p>Peripheral eosinophilia is noted in patients with IP.&#x000a0;The increased production of eosinophils in the bone marrow and increased migration of eosinophils into the circulation causes this eosinophilia. An activated eosinophil secretes granulocyte-macrophage colony-stimulating factor&#x000a0;(GM-CSF), a cytokine that induces eosinophil differentiation and maturation in the bone marrow.&#x000a0;Activated IKK cells have been found to induce elevated expression of GM-CSF in peripheral eosinophils via the NF-kB pathway.<xref ref-type="bibr" rid="article-140417.r21">[21]</xref>&#x000a0;</p>
        <p>GM-CSF works as an autocrine factor to promote eosinophil survival, further elevating peripheral counts. IL-5, a cytokine released by Th2 (T-helper type 2) cells, stimulates the production of eosinophils in the bone marrow and their release into the peripheral blood.&#x000a0;NF-kB pathway activation indirectly stimulates the transcription of IL-5. Currently, the mechanisms of NF-kB pathway activation and T helper cell participation in&#x000a0;IP are not precisely known.&#x000a0;Eotaxin is thought to contribute to tissue eosinophilia in recent studies of the pathophysiology of IP. Several eotaxin promoters possess NF-kB binding sites, including one encoding an eotaxin chemokine previously isolated from blister fluid and crusted scales of patients with IP.<xref ref-type="bibr" rid="article-140417.r22">[22]</xref>&#x000a0;</p>
        <p>Most recently, immunohistochemistry staining of lesional skin from patients with IP revealed strong eotaxin expression on nearly every epidermal layer.&#x000a0;Strong staining for eotaxin was also seen in endothelial cells, and perivascular inflammatory infiltrates.&#x000a0;A high level of eotaxin expression coincided with areas where eosinophils accumulate.</p>
      </sec>
      <sec id="article-140417.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A skin biopsy can be done if genetic testing is inconclusive, particularly in males with suspected incontinentia pigmenti where mosaicism may be present. Histopathologic features can differ based on the stage of skin involvement:<xref ref-type="bibr" rid="article-140417.r23">[23]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 1 (Vesicular): Eosinophilic spongiosis with intraepidermal blister formation.</p>
          </list-item>
          <list-item>
            <p>Stage 2 (Verrucous): Hyperkeratosis, acanthosis, papillomatosis with dyskeratotic keratinocytes.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Stage 3 (hyperpigmented): Abundant melanophages with pigment incontinence, and</p>
          </list-item>
          <list-item>
            <p>Stage 4 (hypopigmented/atrophic): Atrophic epidermis with loss of rete ridge pattern and adnexal structures; and reduction in melanocytes in the basal layer.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140417.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Incontinentia pigmenti is a disorder of the skin, eyes, and central nervous system (CNS)&#x000a0;that&#x000a0;primarily affects females and rarely males. Physical examination findings involving each organ system are listed below.<xref ref-type="bibr" rid="article-140417.r24">[24]</xref></p>
        <p><bold>Cutaneous&#x000a0;findings </bold>of IP are divided into four stages which overlap or occur sequentially.&#x000a0;Dermatologic findings are the first to be observed in IP and present in nearly all patients.&#x000a0;However, the absence of visible cutaneous lesions&#x000a0;does not exclude the diagnosis of IP.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Stage 1, Inflammatory Stage</bold>
<list list-type="bullet"><list-item><p>Vesicular lesions on an erythematous base following Blaschko's lines usually appear at birth or within the first eight weeks of life and persist from 2 weeks to 4 months.</p></list-item><list-item><p>The lesions typically affect the limbs and trunk.</p></list-item><list-item><p>These lesions usually disappear at 18 months of age. These lesions can reappear later in life, even after resolution. Reappearance is noted in the setting of febrile illnesses.<xref ref-type="bibr" rid="article-140417.r25">[25]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Stage 2, Verrucous Stage</bold>
<list list-type="bullet"><list-item><p>Warty papules and plaques are noted in the linear distribution along the lines of Blaschko but not necessarily along the same regions previously affected by the inflammatory stage.</p></list-item><list-item><p>These lesions usually involve the distal limb and scalp. The skin lesions generally appear within the first few months of life as stage I lesions start to resolve.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Stage 3, Hyperpigmented Stage</bold>
<list list-type="bullet"><list-item><p>Whorled slate grey hyperpigmented plaques (marble cake appearance) are seen following Blaschko's lines, and these slowly regress. This is the most typical appearance of IP.&#x000a0;</p></list-item><list-item><p>These lesions are not present at birth, and these usually occur at the age of 6 months to 1 year as stage 2 lesions start to disappear. The specific location is the trunk, axilla, or groin. However, the whole skin surface needs to be examined as the involvement&#x000a0;may be minimal. These lesions usually disappear in adolescence.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Stage 4, Hypopigmented Stage</bold>
<list list-type="bullet"><list-item><p>Pale, hairless linear patches and plaques devoid of sweat glands are most commonly seen on the posterior calves and arms. These lines are chronic.<xref ref-type="bibr" rid="article-140417.r26">[26]</xref><xref ref-type="bibr" rid="article-140417.r27">[27]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p><bold>Hair:</bold>&#x000a0;In roughly 38% of&#x000a0;IP patients, vertex alopecia occurs most commonly in a mild manner and often goes unnoticed.&#x000a0;Alopecia is often associated with inflammation, vesiculation, and scarring. A rare manifestation of IP is agenesis of the eyebrows and eyelashes.</p>
        <p><bold> Nails:&#x000a0;</bold>Approximately 7 to 40% of patients have nail dystrophy.&#x000a0;Ridging, pitting, or nail disruption may occur intermittently and can affect all or most of the fingernails and toenails.<xref ref-type="bibr" rid="article-140417.r28">[28]</xref>&#x000a0;These changes tend to regress and disappear with age. Subungual and periungual keratotic tumors usually present between puberty and the third decade.&#x000a0;The lesions sometimes spontaneously regress but often cause pain, nail dystrophy, and, most importantly, destruction of the bone underneath<bold>.</bold><xref ref-type="bibr" rid="article-140417.r29">[29]</xref></p>
        <p><bold>Teeth: </bold>The features include microdontia, anodontia, hypodontia, and peg-shaped teeth.&#x000a0;Some significant dental abnormalities are microdontia, delayed eruption of permanent teeth, and cleft palate.<xref ref-type="bibr" rid="article-140417.r30">[30]</xref></p>
        <p><bold>CNS: </bold>Central nervous system deficits constitute a significant threat to the normal life span of patients with IP. When coupled with ophthalmic manifestations, these may significantly reduce patients' quality of life. Approximately 30% of IP patients have neurologic impairments.&#x000a0;Neurologic involvement is often present along with retinal vasculopathy and may result from ischemia/vaso-occlusive events.<xref ref-type="bibr" rid="article-140417.r31">[31]</xref></p>
        <p>About 13% of infants develop infantile spasms and seizure disorders.&#x000a0;There is also an increased risk of spastic paralysis, and 7.5% of patients develop motor dysfunction.&#x000a0;Early seizures may result from abnormal neuronal and neural crest cell migration, leading to gross brain malformations. Other manifestations include congenital hearing loss, cerebellar ataxia, muscular paralysis, mental disability, and aseptic encephalomyelitis.</p>
        <p><bold>Ophthalmologic:</bold> The<bold>&#x000a0;</bold>risk of ophthalmologic abnormalities is 20 to 37%.<xref ref-type="bibr" rid="article-140417.r32">[32]</xref><xref ref-type="bibr" rid="article-140417.r33">[33]</xref>&#x000a0;However, up to 77% of cases may have ocular involvement.</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Retina:</bold>&#x000a0;Peripheral retinal capillary nonperfusion (ischemia) is noted. New vessels may give rise to vitreous hemorrhage or tractional retinal detachment. Exudative retinal detachments may also be noted. The risk&#x000a0;of retinal detachment is most significant in infancy and childhood. The findings at the posterior pole&#x000a0;include foveal hypoplasia,&#x000a0;RPE (retinal pigment epithelium) mottling, areas of capillary nonperfusion surrounded by vascular loops, macular ischemia, epiretinal membrane,&#x000a0;neovascularization of the optic disc, Roth spots, paramacular dilation of vessels, and aneurysms. The changes in the peripheral retina may also progress towards the posterior pole. The changes seen in the peripheral retina include:<xref ref-type="bibr" rid="article-140417.r34">[34]</xref><xref ref-type="bibr" rid="article-140417.r35">[35]</xref>
<list list-type="bullet"><list-item><p>Peripheral avascular retina</p></list-item><list-item><p>Aneurysm like dilation</p></list-item><list-item><p>Arteriovenous anastomosis, vascular loops similar to those seen in aggressive retinopathy of prematurity (ROP)</p></list-item><list-item><p>Retinal and extraretinal new vessels</p></list-item><list-item><p>Preretinal fibrovascular proliferation</p></list-item><list-item><p>Vitreous hemorrhage</p></list-item><list-item><p>Retinal detachment (tractional or exudative)</p></list-item><list-item><p>Exudates</p></list-item><list-item><p>Mottling of RPE</p></list-item><list-item><p>Hypopigmented lesions</p></list-item><list-item><p>Coloboma</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Other eye findings:&#x000a0;</bold>Strabismus, cataracts, conjunctival pigmentation, optic atrophy, retinal pigment abnormalities, foveal hypoplasia, foveal disorganization, and microphthalmia are less common eye findings.<xref ref-type="bibr" rid="article-140417.r36">[36]</xref>&#x000a0;The end-stage disease is characterized by phthisis&#x000a0;or absolute glaucoma. The visual decline may also be related to brain disorders leading to cortical blindness.</p>
          </list-item>
        </list>
        <p><bold>Breast:</bold>&#x000a0;The presence of abnormalities of mammary tissue, ranging from aplasia of the breast, breast hypoplasia, nipple hypoplasia, to excessive nipples, may occur, and it is more common than in the general population.</p>
      </sec>
      <sec id="article-140417.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis of incontinentia pigmenti is based on clinical findings. Pediatricians and dermatologists&#x000a0;are usually the first to diagnose the disease during infancy. Experts have established major and minor criteria&#x000a0;to help make the diagnosis.&#x000a0;Diagnostic criteria for&#x000a0;IP have been suggested by Landy and Donnai.</p>
        <p>If the first-degree female relative does not show evidence of IP, the <bold>m</bold><bold>ajor criteria</bold> include<xref ref-type="bibr" rid="article-140417.r28">[28]</xref></p>
        <p>
<bold>Typical Neonatal Rash </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Erythema</p>
          </list-item>
          <list-item>
            <p>Vesicles</p>
          </list-item>
          <list-item>
            <p>Eosinophilia</p>
          </list-item>
        </list>
        <p>
<bold>Typical Hyperpigmentation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Mainly trunk</p>
          </list-item>
          <list-item>
            <p>Blaschko's lines</p>
          </list-item>
          <list-item>
            <p>Fading in adolescence</p>
          </list-item>
        </list>
        <p>
<bold>Linear, Atrophic, Hairless Lesions</bold>
</p>
        <p><bold>Minor criteria </bold>or 'supportive evidence'&#x000a0;in cases not showing evidence of IP in a first-degree female relative include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dental involvement</p>
          </list-item>
          <list-item>
            <p>Alopecia</p>
          </list-item>
          <list-item>
            <p>Woolly hair/abnormal nails</p>
          </list-item>
          <list-item>
            <p>Retinal disease</p>
          </list-item>
        </list>
        <p>At least one of the major criteria is necessary to confirm a diagnosis, but minor criteria support the diagnosis of sporadic IP.&#x000a0;The absence of all minor criteria makes the diagnosis of IP 'uncertain.' If there is evidence of IP in a first-degree female relative, then the following features are needed either alone or in combination:<xref ref-type="bibr" rid="article-140417.r28">[28]</xref></p>
        <p>
<bold>Suggestive History or Evidence of Typical Rash </bold>
</p>
        <p>
<bold>Skin manifestations of IP </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hyperpigmentation</p>
          </list-item>
          <list-item>
            <p>Scarring</p>
          </list-item>
          <list-item>
            <p>Hairless streaks</p>
          </list-item>
          <list-item>
            <p>Alopecia at vertex</p>
          </list-item>
        </list>
        <p>
<bold>Anomalous Dentition </bold>
</p>
        <p>
<bold>Woolly Hair </bold>
</p>
        <p>
<bold>Retinal Disease </bold>
</p>
        <p>
<bold>Multiple Male Miscarriages</bold>
</p>
        <p>Recently, the diagnostic criteria of IP have been revised to include the four stages of IP skin lesions as significant criteria.&#x000a0;The minor criteria or the supportive evidence include 'dental anomalies, ocular anomalies, CNS anomalies, alopecia, abnormal hair (sparse hair, wooly hair, anomalies of eyebrows and eyelashes), abnormal nails, *alate anomalies, nipple and breast anomalies, multiple male miscarriages, and typical skin pathohistological findings.'&#x000a0;According to this revised diagnostic criteria by&#x000a0;Minic and colleagues, the conditions needed to establish the diagnosis of IP include:<xref ref-type="bibr" rid="article-140417.r10">[10]</xref></p>
        <p><bold>No evidence of IP in a first-degree female relative:</bold> If lacking genetic IKBKG mutation data, at least two or more major criteria or one major and one or more minor criteria are necessary to make a diagnosis of sporadic IP,</p>
        <p><bold> In the case of confirmed IKBKG mutation typical for IP:</bold> any single major or minor criterion is satisfactory for IP diagnosis,</p>
        <p><bold>Evidence of IP in a first-degree female relative</bold>: Any single major or at least two minor criteria,</p>
        <p><bold> In all cases:</bold> eosinophilia and skewed X-chromosome inactivation support diagnosis.</p>
        <p>If clinical features are not evident, molecular genetic testing to identify IKBKG mutation is diagnostic. The most effective molecular genetic testing is single-gene testing.&#x000a0;A skin biopsy can also be considered. Histopathologic features will vary based on the stage of clinical findings.</p>
        <p>Ocular investigations include fundus photo, fundus fluorescein angiogram (FFA),&#x000a0;optical coherence tomography (OCT) of the retina, and OCT-angiography (OCTA). FFA features include abnormal vascular loops, capillary nonperfusion areas, vascular anastomoses, pathologically straightened peripheral retinal vessels, and new vessels.<xref ref-type="bibr" rid="article-140417.r37">[37]</xref>&#x000a0;Abnormalities seen on OCT macula include irregularities in the outer plexiform layer, thinning of the inner retina, epiretinal membrane, and macular pseudohole.&#x000a0;OCTA abnormalities are noted in almost all eyes.&#x000a0;The abnormalities include abnormal vascular loops, loss of flow in deep and superficial capillary plexuses (corroborating with retinal thinning seen on OCT), and reduced vascular density.<xref ref-type="bibr" rid="article-140417.r38">[38]</xref></p>
        <p>Neuroimaging plays an important part in the diagnosis of CNS involvement.</p>
      </sec>
      <sec id="article-140417.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The involvement of multiple organ systems in incontinentia pigmenti requires a multidisciplinary approach to management.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric dermatology should be consulted for the management of cutaneous lesions.
<list list-type="bullet"><list-item><p>An early blistering rash can be misdiagnosed&#x000a0;as congenital herpes simplex, epidermolysis bullosa, and varicella.</p></list-item><list-item><p>All stages of skin lesions should be kept cool and dry, and devoid of trauma.</p></list-item><list-item><p>All stages of skin lesions can overlap in the first year of life and recur after the disappearance in the setting of infection or viral illness.</p></list-item><list-item><p>Hypohidrosis occurs in IP, which results in heat intolerance and the risk of life-threatening overheating.<xref ref-type="bibr" rid="article-140417.r25">[25]</xref>&#x000a0;Therefore, measures for cooling should be undertaken, including cool baths, use of ice packs, and shade.</p></list-item><list-item><p>No specific therapies have been established for cutaneous lesions. Treatment is focused on wound care and treatment of secondary infections as needed.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>A pediatric ophthalmologist should be consulted to examine the retina and periodic follow-ups.&#x000a0;
<list list-type="bullet"><list-item><p>A dilated fundus examination should be performed to evaluate the optic nerve, macula, and retinal periphery.</p></list-item><list-item><p>A retina specialist should re-evaluate abnormal findings</p></list-item><list-item><p>The goal is to prevent retinal detachment or vitreous hemorrhage secondary to retinal neovascularization.</p></list-item><list-item><p>The peripheral avascular retina is treated with laser photocoagulation similar to retinopathy of prematurity.</p></list-item><list-item><p>Retinal detachment and vitreous hemorrhage may require pars plana vitrectomy.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Pediatric neurology consultation is needed for the management of seizures and neurologic imaging.
<list list-type="bullet"><list-item><p>Baseline magnetic resonance imaging (MRI)&#x000a0;with or without contrast during the neonatal period is recommended to establish baseline neurologic imaging.</p></list-item><list-item><p>Repeat imaging in seizures and other neurologic abnormalities can be performed.</p></list-item><list-item><p>Seizures are the most common neurologic manifestation.&#x000a0;An electroencephalogram (EEG) may be considered in the setting of seizures.&#x000a0;A periodic follow-up to assess for focal motor deficits and delay in developmental milestones is necessary.<xref ref-type="bibr" rid="article-140417.r15">[15]</xref>&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>A genetic counselor and a geneticist can help in genetic testing. Approximately 25 to 35% of cases are familial, and the rest are sporadic.&#x000a0;A thorough exam of patients and at-risk relatives can help determine inheritance. If there are no physical findings, molecular genetic testing for a mutation in the IKBKG gene can be done if the diagnosis is suspected.</p>
          </list-item>
          <list-item>
            <p>Follow-up with the pediatrician is necessary to screen for developmental delays. Neuropsychiatry testing for children who are struggling with school activities is essential.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Other systemic complications include damage to the microvasculature&#x000a0;and pulmonary hypertension without cardiovascular disease.</p>
          </list-item>
          <list-item>
            <p>In pregnancy, fertility is not impaired in women with IP,&#x000a0;but the risk of spontaneous abortion is higher for those carrying a male fetus.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Women with IP considering pregnancy should have prenatal testing and counseling.&#x000a0;Males with&#x000a0;IP have somatic mosaicism, not a germline mutation; therefore, transmission from an affected male to a daughter is unlikely.<xref ref-type="bibr" rid="article-140417.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140417.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses of incontinentia pigmenti can vary based on the stage of skin lesions. These include:<xref ref-type="bibr" rid="article-140417.r39">[39]</xref></p>
        <p>
<bold>Stage 1 (vesicular)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Congenital herpes simplex can present with grouped hemorrhagic vesicles, often on the scalp and at sites of trauma from scalp electrodes. Lesions can be present at birth or appear within the first few weeks of life.<xref ref-type="bibr" rid="article-140417.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Bullous impetigo,</p>
          </list-item>
          <list-item>
            <p>Epidermolysis bullosa, and</p>
          </list-item>
          <list-item>
            <p>Congenital ichthyosiform erythroderma.</p>
          </list-item>
        </list>
        <p><bold>Stage 2 (verrucous)</bold> - linear epidermal nevus and lichen striatus</p>
        <p><bold>Stage 3 (hyperpigmented)</bold> - linear and whorled nevoid hype melanosis</p>
        <p><bold>Stage 4 (atrophic/hypopigmented)</bold> - hypomelanosis of Ito, Goltz syndrome( focal dermal hypoplasia).</p>
        <p>Differential diagnoses of retinal features of IP include ROP, FEVR (familial exudative vitreoretinopathy), and Norrie disease. IP is an important cause of leukocoria.<xref ref-type="bibr" rid="article-140417.r41">[41]</xref></p>
      </sec>
      <sec id="article-140417.s11" sec-type="Staging">
        <title>Staging</title>
        <p>Vitreoretinal changes noted in IP are classified into five stages:<xref ref-type="bibr" rid="article-140417.r34">[34]</xref></p>
        <p><bold>Stage 1</bold>- Retinal pigment epithelial changes only,</p>
        <p><bold>Stage 2</bold> - Retinal vascular abnormalities (except neovascularization),</p>
        <p><bold>Stage 3</bold> -&#x000a0;Retinopathy with neovascularization or other pathologies secondary to retinal vasculopathy, such as retinal exudation, epiretinal membrane/proliferation, or vitreous hemorrhage,</p>
        <p><bold>Stage 4</bold> -&#x000a0;Retinal detachment without end-stage changes</p>
        <list list-type="bullet">
          <list-item>
            <p>4a: partial retinal detachment;</p>
          </list-item>
          <list-item>
            <p>4b: total retinal detachment, and</p>
          </list-item>
        </list>
        <p><bold>Stage 5</bold> - End stage: severe ocular complications such as phthisis bulbi and secondary glaucoma.</p>
      </sec>
      <sec id="article-140417.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis is variable and based on the degree of skin and organ involvement. There are no significant sequelae secondary to skin manifestations. However, the severity of eye and CNS abnormalities pose the highest morbidity and mortality. In addition, patients with seizures and structural CNS abnormalities have the greatest developmental delay and impairment risk. Patients without significant ophthalmic or neurological impairment have a good prognosis and a normal life expectancy.<xref ref-type="bibr" rid="article-140417.r42">[42]</xref></p>
      </sec>
      <sec id="article-140417.s13" sec-type="Complications">
        <title>Complications</title>
        <p>In a&#x000a0;newborn, the goal is to reduce the risk of infection of blisters, in addition to standard medical management of skin lesions. Careful monitoring for systemic involvement is prudent during this time. The possibility of retinal detachment, particularly in children under seven years of age, is an important consideration, and ophthalmologic screening is necessary. Head trauma can also increase the risk of retinal detachment;&#x000a0;however, no specific recommendations are currently established for avoiding contact sports.&#x000a0;A suggested schedule for eye examinations is monthly until age four months, every three months from 4 months to 1 year of age, then every six months between age one to three, and annually after that.<bold>&#x000a0;</bold>The neurologic function requires routine assessment, and ongoing dental screening is appropriate.<xref ref-type="bibr" rid="article-140417.r4">[4]</xref></p>
      </sec>
      <sec id="article-140417.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Support and advocacy groups help patients and families find valuable services. To establish the best professional and social resources, it is imperative to seek help from experts and receive an early diagnosis. Rare diseases are challenging to diagnose and require genetic testing and a multidisciplinary approach. For families with limited health literacy or resources, this may be a challenging undertaking. Dermatologists and pediatricians are uniquely positioned to help patients find the right support network as they are often a patient's first point of contact.</p>
        <p>Patients and families can learn more about IP by visiting the following websites of the following organizations:</p>
        <list list-type="bullet">
          <list-item>
            <p>Incontinentia Pigmenti International Foundation</p>
          </list-item>
          <list-item>
            <p>National Organization for Rare Diseases</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140417.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Providing medical care and support to individuals and families with incontinentia pigmenti requires a multidisciplinary approach. Follow-up with multiple specialties includes ophthalmology for annular eye exams throughout life and geneticist for risk assessment for older and younger at-risk relatives. Rare diseases like&#x000a0;IP have an overall low incidence, so establishing treatment protocols is difficult. Support for families can also prove to be a challenge due to this.</p>
      </sec>
      <sec id="article-140417.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140417&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140417">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/incontinentia-pigmenti-bloch-sulzberger-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140417">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140417/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140417">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140417.s17">
        <fig id="article-140417.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Infant with incontinentia pigmenti <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="incontinentia-pigmenti-5" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140417.s18">
        <fig id="article-140417.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Incontinentia Pigmenti <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="incontinentia-pigmenti-6" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140417.s19">
        <title>References</title>
        <ref id="article-140417.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berlin</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>47</volume>
            <issue>2</issue>
            <fpage>169</fpage>
            <page-range>169-87; quiz 188-90</page-range>
            <pub-id pub-id-type="pmid">12140463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ardelean</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti in boys: a series and review of the literature.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2006</year>
            <season>Nov-Dec</season>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>523</fpage>
            <page-range>523-7</page-range>
            <pub-id pub-id-type="pmid">17155991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greene-Roethke</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia Pigmenti: A&#x000a0;Summary Review of This Rare Ectodermal Dysplasia With Neurologic Manifestations, Including Treatment Protocols.</article-title>
            <source>J Pediatr Health Care</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>e45</fpage>
            <page-range>e45-e52</page-range>
            <pub-id pub-id-type="pmid">28870493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheuerle</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti in adults.</article-title>
            <source>Am J Med Genet A</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>179</volume>
            <issue>8</issue>
            <fpage>1415</fpage>
            <page-range>1415-1419</page-range>
            <pub-id pub-id-type="pmid">31119873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luo</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kamata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Karin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.</article-title>
            <source>J Clin Invest</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>115</volume>
            <issue>10</issue>
            <fpage>2625</fpage>
            <page-range>2625-32</page-range>
            <pub-id pub-id-type="pmid">16200195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Courtois</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Smahi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>NF-kappaB-related genetic diseases.</article-title>
            <source>Cell Death Differ</source>
            <year>2006</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>843</fpage>
            <page-range>843-51</page-range>
            <pub-id pub-id-type="pmid">16397577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Song</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Na</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>A Case of a Surviving Male Infant with Incontinentia Pigmenti.</article-title>
            <source>Ann Dermatol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>134</fpage>
            <page-range>134-7</page-range>
            <pub-id pub-id-type="pmid">27303177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Happle</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>X-chromosome inactivation: role in skin disease expression.</article-title>
            <source>Acta Paediatr Suppl</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>451</issue>
            <fpage>16</fpage>
            <page-range>16-23</page-range>
            <pub-id pub-id-type="pmid">16720460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Happle</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Lyonization and the lines of Blaschko.</article-title>
            <source>Hum Genet</source>
            <year>1985</year>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>200</fpage>
            <page-range>200-6</page-range>
            <pub-id pub-id-type="pmid">3894210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mini&#x00107;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Trpinac</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Obradovi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti diagnostic criteria update.</article-title>
            <source>Clin Genet</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>536</fpage>
            <page-range>536-42</page-range>
            <pub-id pub-id-type="pmid">23802866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mini&#x00107;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Trpinac</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Obradovi&#x00107;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Systematic review of central nervous system anomalies in incontinentia pigmenti.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2013</year>
            <month>Feb</month>
            <day>13</day>
            <volume>8</volume>
            <fpage>25</fpage>
            <pub-id pub-id-type="pmid">23406512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fusco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Paciolla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Conte</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Pescatore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mirabelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lioi</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Ursini</surname>
                <given-names>MV</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti: report on data from 2000 to 2013.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2014</year>
            <month>Jun</month>
            <day>24</day>
            <volume>9</volume>
            <fpage>93</fpage>
            <pub-id pub-id-type="pmid">24961275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldberg</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Custis</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome).</article-title>
            <source>Ophthalmology</source>
            <year>1993</year>
            <month>Nov</month>
            <volume>100</volume>
            <issue>11</issue>
            <fpage>1645</fpage>
            <page-range>1645-54</page-range>
            <pub-id pub-id-type="pmid">8233390</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poziomczyk</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Recuero</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Bringhenti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maria</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Travi</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Freitas</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Maahs</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zen</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Fiegenbaum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Almeida</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Bonamigo</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Bau</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti.</article-title>
            <source>An Bras Dermatol</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-36</page-range>
            <pub-id pub-id-type="pmid">24626645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Courtois</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ursini</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Schwaninger</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>New Insight Into the Pathogenesis of Cerebral Small-Vessel Diseases.</article-title>
            <source>Stroke</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>520</fpage>
            <page-range>520-527</page-range>
            <pub-id pub-id-type="pmid">28082670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Joo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>NF-&#x003ba;B signaling in inflammation.</article-title>
            <source>Signal Transduct Target Ther</source>
            <year>2017</year>
            <volume>2</volume>
            <fpage>17023</fpage>
            <page-range>17023-</page-range>
            <pub-id pub-id-type="pmid">29158945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oeckinghaus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The NF-kappaB family of transcription factors and its regulation.</article-title>
            <source>Cold Spring Harb Perspect Biol</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>a000034</fpage>
            <pub-id pub-id-type="pmid">20066092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smahi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Courtois</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vabres</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yamaoka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heuertz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Munnich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Isra&#x000eb;l</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Heiss</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Klauck</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kioschis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wiemann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Poustka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Esposito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bardaro</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gianfrancesco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ciccodicola</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D'Urso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Woffendin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jakins</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Donnai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kenwrick</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Aradhya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamagata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.</article-title>
            <source>Nature</source>
            <year>2000</year>
            <month>May</month>
            <day>25</day>
            <volume>405</volume>
            <issue>6785</issue>
            <fpage>466</fpage>
            <page-range>466-72</page-range>
            <pub-id pub-id-type="pmid">10839543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biancalana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Natan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lenardo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Fersht</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>NF-&#x003ba;B Rel subunit exchange on a physiological timescale.</article-title>
            <source>Protein Sci</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>9</issue>
            <fpage>1818</fpage>
            <page-range>1818-1832</page-range>
            <pub-id pub-id-type="pmid">34089216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shih</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Tsui</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caldwell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A single NF&#x003ba;B system for both canonical and non-canonical signaling.</article-title>
            <source>Cell Res</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-102</page-range>
            <pub-id pub-id-type="pmid">21102550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takematsu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Terui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Torinuki</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tagami</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti: eosinophil chemotactic activity of the crusted scales in the vesiculobullous stage.</article-title>
            <source>Br J Dermatol</source>
            <year>1986</year>
            <month>Jul</month>
            <volume>115</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-6</page-range>
            <pub-id pub-id-type="pmid">3015188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Higuchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ichiki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sasai</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Demonstration of eosinophil chemotactic factor in the blister fluid of patient with incontinentia pigmenti.</article-title>
            <source>J Dermatol</source>
            <year>1985</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>363</fpage>
            <page-range>363-8</page-range>
            <pub-id pub-id-type="pmid">3910694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ehrenreich</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tarlow</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Godlewska-Janusz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder.</article-title>
            <source>Cutis</source>
            <year>2007</year>
            <month>May</month>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>355</fpage>
            <page-range>355-62</page-range>
            <pub-id pub-id-type="pmid">17569396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alshenqiti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nashabat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>AlGhoraibi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tamimi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Alfadhel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report.</article-title>
            <source>Ther Clin Risk Manag</source>
            <year>2017</year>
            <volume>13</volume>
            <fpage>629</fpage>
            <page-range>629-634</page-range>
            <pub-id pub-id-type="pmid">28533687</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Leeuwen</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Wintzen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Praag</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti: an extensive second episode of a "first-stage" vesicobullous eruption.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2000</year>
            <season>Jan-Feb</season>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>70</fpage>
            <pub-id pub-id-type="pmid">10720994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moss</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ince</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Anhidrotic and achromians lesions in incontinentia pigmenti.</article-title>
            <source>Br J Dermatol</source>
            <year>1987</year>
            <month>Jun</month>
            <volume>116</volume>
            <issue>6</issue>
            <fpage>839</fpage>
            <page-range>839-49</page-range>
            <pub-id pub-id-type="pmid">3620344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nazzaro</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Brusasco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gelmetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ermacora</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Hypochromic reticulated streaks in incontinentia pigmenti: an immunohistochemical and ultrastructural study.</article-title>
            <source>Pediatr Dermatol</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>174</fpage>
            <page-range>174-8</page-range>
            <pub-id pub-id-type="pmid">2247383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landy</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Donnai</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti (Bloch-Sulzberger syndrome).</article-title>
            <source>J Med Genet</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-9</page-range>
            <pub-id pub-id-type="pmid">8423608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carney</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti. A world statistical analysis.</article-title>
            <source>Arch Dermatol</source>
            <year>1976</year>
            <month>Apr</month>
            <volume>112</volume>
            <issue>4</issue>
            <fpage>535</fpage>
            <page-range>535-42</page-range>
            <pub-id pub-id-type="pmid">1267462</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hadj-Rabia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Froidevaux</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bodak</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hamel-Teillac</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Smahi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Touil</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fraitag</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>de Prost</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bodemer</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Clinical study of 40 cases of incontinentia pigmenti.</article-title>
            <source>Arch Dermatol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>139</volume>
            <issue>9</issue>
            <fpage>1163</fpage>
            <page-range>1163-70</page-range>
            <pub-id pub-id-type="pmid">12975158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francis</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sybert</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti.</article-title>
            <source>Semin Cutan Med Surg</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-60</page-range>
            <pub-id pub-id-type="pmid">9125766</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fusco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Fergola</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pescatore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lioi</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Ursini</surname>
                <given-names>MV</given-names>
              </name>
            </person-group>
            <article-title>The Incontinentia Pigmenti Genetic Biobank: study design and cohort profile to facilitate research into a rare disease worldwide.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>1509</fpage>
            <page-range>1509-1518</page-range>
            <pub-id pub-id-type="pmid">31231133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meuwissen</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Neurological findings in incontinentia pigmenti; a review.</article-title>
            <source>Eur J Med Genet</source>
            <year>2012</year>
            <month>May</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>323</fpage>
            <page-range>323-31</page-range>
            <pub-id pub-id-type="pmid">22564885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>She</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti-associated ocular anomalies of paediatric incontinentia pigmenti patients in China.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2019</year>
            <month>May</month>
            <volume>97</volume>
            <issue>3</issue>
            <fpage>265</fpage>
            <page-range>265-272</page-range>
            <pub-id pub-id-type="pmid">30073775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sindhu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jinagal</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Retinal imaging in incontinentia pigmenti.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>944</fpage>
            <page-range>944-945</page-range>
            <pub-id pub-id-type="pmid">31124523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Temkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pushker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>Phthisis Bulbi-a Clinicopathological Perspective.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2018</year>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>788</fpage>
            <page-range>788-803</page-range>
            <pub-id pub-id-type="pmid">29902388</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Optical Coherence Tomography Angiography and Ultra-Widefield Optical Coherence Tomography in a Child With Incontinentia Pigmenti.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2018</year>
            <month>Apr</month>
            <day>01</day>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>273</fpage>
            <page-range>273-275</page-range>
            <pub-id pub-id-type="pmid">29664986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>TYA</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Linz</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Multimodal Retinal Imaging in Incontinentia Pigmenti Including Optical Coherence Tomography Angiography: Findings From an Older Cohort With Mild Phenotype.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2018</year>
            <month>May</month>
            <day>01</day>
            <volume>136</volume>
            <issue>5</issue>
            <fpage>467</fpage>
            <page-range>467-472</page-range>
            <pub-id pub-id-type="pmid">29566114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swinney</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Karth</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia Pigmenti: A Comprehensive Review and Update.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>46</volume>
            <issue>6</issue>
            <fpage>650</fpage>
            <page-range>650-7</page-range>
            <pub-id pub-id-type="pmid">26114846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kimberlin</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Herpes simplex virus infections of the newborn.</article-title>
            <source>Semin Perinatol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-25</page-range>
            <pub-id pub-id-type="pmid">17317423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r41">
          <label>41</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kanukollu</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Leukocoria</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">32809629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140417.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez-Gayosso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Romero</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti: multisistemic genodermatosis.</article-title>
            <source>Bol Med Hosp Infant Mex</source>
            <year>2020</year>
            <volume>77</volume>
            <issue>3</issue>
            <fpage>112</fpage>
            <page-range>112-118</page-range>
            <pub-id pub-id-type="pmid">32496467</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
